期刊文献+

医院抗菌药物使用量与鲍曼不动杆菌耐药的相关性研究 被引量:12

Correlation between Antibacterial Consumption and Antibacterial Resistance Rates of Acinetobacter Baumannii in Hospital
下载PDF
导出
摘要 目的对2006~2010年5年间某医院住院病区抗菌药物使用量与痰培养鲍曼不动杆菌耐药变化之间的相关性进行评价。方法根据11种抗菌药物平均每日每百张床位所消耗的用药频度(DDDs/100BD)与同期抗菌药物对鲍曼不动杆菌的耐药率,对抗菌药物使用量与耐药率进行相关性统计分析。结果亚胺培南、美罗培南使用量分别与鲍曼不动杆菌对亚胺培南耐药率显著相关,有统计学意义(r=0.939,P=0.005;r=0.880,P=0.021);亚胺培南、美罗培南使用量与鲍曼不动杆菌对美罗培南耐药率显著相关,亦有统计学意义(r=0.972,P=0.001;r=0.911,P=0.012);莫西沙星使用量与鲍曼不动杆菌对亚胺培南、美罗培南耐药率的相关性有统计学意义(r=0.878,P=0.023;r=0.865,P=0.026);其他组数据无统计学意义。结论某医院抗菌药物使用量与鲍曼不动杆菌耐药水平变化之间存在相关关系,这种发现有助于针对抗菌药物高消耗量以及细菌耐药率高的住院病区优化抗菌药物使用策略。 Objective To investigate whether there is a correlation between the rates of antibacterial consumption and the prevalence of antibacterial resistance in Acinet0bacter baumannii in the hospital. Methods Data on antibacterial consumption (from January 2006 to December 2010) were expressed as defined daily doses per 100 bed-days. Rates of antibacterial resistance in Acinetobacter baumannii were collected, and their correlation was analyzed. Results The consumption of imipenem/cilastatin, meropenem was significantly correlated with imipenem resistance in A baumannii ( r =0. 939, P = 0. 005 ; r = 0. 880, P = 0. 021 ). The consumption of imipenem/cilastatin, meropenem was significantly correlated with meropenem resistance in A baumannii (r = 0. 972, P = 0. 001 ; r = 0. 9I 1, P = 0. 012 ). Furthermore, Consumption of moxifloxacin was significantly correlated with A baumannii resistance to imipenem/cilastatin, meropenem (r = 0. 878, P = 0. 023 ; r = 0. 865, P = 0. 026). There were no significant correlation in other drugs. Conclusion There is a relationship between antibacterial consumption and the prevalence of antibacterial resistance in the hospital. These findings may help to optimize antibacterial prescription policies in the hospital, especially in departments that have both high rates of antibacterial consumption and a high prevalence of antibacterial resistance.
出处 《今日药学》 CAS 2012年第8期489-492,共4页 Pharmacy Today
基金 广东省医学科研基金(编号:A2012247) 广东省高等学校大学生创新实验项目(编号:20111006)
关键词 抗菌药物用量 鲍曼不动杆菌 耐药性 多药耐药 antibacterial consumption Acinetobacter baumannii antibacterial resistance multi-drug resisitance
  • 相关文献

参考文献16

  • 1习慧明,徐英春,朱德妹,汪复,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳,俞云松,杨青.2010年中国CHINET鲍曼不动杆菌耐药性监测[J].中国感染与化疗杂志,2012,12(2):98-104. 被引量:212
  • 2Empey KM,Rapp RP,Evans ME. The effect of an antimicrobial formulary change on hospital resistance patterns[J].Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy,2002,(01):81-87. 被引量:1
  • 3Monroe S,Polk R. Antimicrobial use and bacterial resistance[J].Current Opinion in Biotechnology,2000,(03):496-501. 被引量:1
  • 4Levy SB. The 2000 Garrod lecture.Factors impacting on the problem of antibiotic resistance[J].Journal of Antimicrobial Chemotherapy,2002,(01):25-30. 被引量:1
  • 5Garnacho-Montero J,Amaya-Villar R. Multiresistant Acinetobacter baumannii infections:epidemiology and management[J].Current Opinion in Infectious Diseases,2010,(04):332-339. 被引量:1
  • 6Fishbain J,Peleg AY. Treatment of Acinetobacter infections[J].Clinical Infectious Diseases,2010,(01):79-84. 被引量:1
  • 7Higgins PG,Dammhayn C,Hackel M. Global spread of carbapenem-resistantAcinetobacter baumannii[J].Journal of Antimicrobial Chemotherapy,2010,(02):233-238. 被引量:1
  • 8Leibovici L,Berger R,Gruenewald T. Departmental consumption of antibiotic drugs and subsequent resistance:a quantitative link[J].Journal of Antimicrobial Chemotherapy,2001,(04):535-540. 被引量:1
  • 9Paterson DL. "Collateral damage" from cephalosporin or quinolone antibiotic therapy[J].Clini Infectious Dis,2004,(38 Suppl 4):S341-S345. 被引量:1
  • 10Iosifidis E,Antachopoulos C,Tsivitanidou M. Differeutial correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece[J].Infection Control and Hospital Epidemiology,2008,(07):615-622. 被引量:1

二级参考文献13

  • 1张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 2Clinical and Laboratory Standards Institute. Performancestandards for antimicrobial susceptibility testing~ twentieth information- al supplement[S]. CLSI, 2010,30 ( 1 ) : M100-S20. 被引量:1
  • 3Peleg AY, Seifert H, Paterson DL. Acinetobacterbauman- nil: emergence of a successful pathogen[J]. Clin Microbiol Rev,2008,21(3) :538-582. 被引量:1
  • 4Choi WS, Kim SH, Jeon EG, et al. Nosoeomial outbreak of carbapenem-resistant Acinetobacter baumannii in Intensive Care Units and successful outbreak control program[J]. J Korean Med Sci,2010, 25(7) :999-1004. 被引量:1
  • 5NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992through June 2003, issued August 2003 [J]. Am J Infect Control, 2003,31 (8) : 481 498. 被引量:1
  • 6Karageorgopoulous DE, Falagas ME. Current control and treatment of multidrug-resistant aclnetobacter baumannii in- fections[J]. Lancet Infect Dis, 2008,8 (12): 751-762. 被引量:1
  • 7Perez F, Hujer AM, Hujer KM, et al. Global Challenge of multidrug-resistant Acinetobacter baumannii [ J ]. Antimicrob Agents Chemother, 2007,51 (10) : 3471-3484. 被引量:1
  • 8Y Doi, Husain S, Potoski BA, et al. Extensively drug-resist- ant Acinetobacter baumannii [J ]. Emerg Infect Dis, 2009,15 (6):980-982. 被引量:1
  • 9Bassetti M, Righi E, Esposito S, et al. Drug treatment for multidrug-resistant Acinetobacter baumannii infections [J]. Future Microbiol, 2008,3 (6) .. 649-660. 被引量:1
  • 10Durante-Mangoni E, Zarrilli R. Global spread of drug-resist- ant Acinetobacter baumannii molecular epidemiology and management of antimicrobial resistance[J]. Future Microbi- ol,2011,6(4) :407-422. 被引量:1

共引文献211

同被引文献113

引证文献12

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部